Clinical Trials Logo
  1. Home
  2. Interstitial Lung Disease
  3. NCT01055730
  4. Details
NCT01055730 Clinical Trial

The Impact of Pulmonary Rehabilitation in Interstitial Lung Disease

Interstitial Lung Disease Clinical Trial

— PR-ILD  

Official title:
The Impact of Pulmonary Rehabilitation in Interstitial Lung Disease: A Prospective Cohort Study

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT01055730
Other study ID # PR-ILD
Secondary ID
Status Completed
Phase N/A
First received January 25, 2010
Last updated November 19, 2013
Start date February 2010
Est. completion date January 2013

Study information
Verified date November 2013
Source University of California, San Francisco
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

The purpose of this study is to determine if pulmonary rehabilitation has any effect on breathlessness, quality of life, physical function and depression in persons with interstitial lung disease.

Recruitment information / eligibility
Status Completed
Enrollment 54
Est. completion date January 2013
Est. primary completion date January 2013
Accepts healthy volunteers No
Gender Both
Age group 19 Years and older
Eligibility Inclusion Criteria:

- Adults (> 18 years old) with a diagnosis of ILD who are referred to a participating PR program

Exclusion Criteria:

- Inability to provide informed consent

- Inability to read and write English

- Any other medical condition that significantly limits the subject's ability to perform the functional measures

- Emphysema / Chronic bronchitis (FEV1 / FVC ratio < 60%)

- Previous pulmonary rehabilitation

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Intervention

Other:
• Pulmonary rehabilitation
Structured education and supervised exercise program, lasting between 6 and 9 weeks.

Locations
Country Name City State
Canada University of British Columbia Vancouver British Columbia
United States John Muir Health Concord California
United States Seton Pulmonary & Cardiac Rehabilitation Daly City California
United States Duke University Medical Center Durham North Carolina
United States Inova Fairfax Hospital Falls Church Virginia
United States Yale University School of Medicine New Haven Connecticut

Sponsors (1)
Lead Sponsor Collaborator
University of California, San Francisco

Countries where clinical trial is conducted

United States,  Canada, 

Outcome
Type Measure Description Time frame Safety issue
Primary 6-minute walk distance Immediately following completion of pulmonary rehabilitation and 6 months following the start of pulmonary rehabilitation No
Primary Quality of life Immediately following completion of pulmonary rehabilitation and 6 months following the start of pulmonary rehabilitation No
Secondary Dyspnea Immediately following completion of pulmonary rehabilitation and 6 months following the start of pulmonary rehabilitation No
Secondary Depression Immediately following completion of pulmonary rehabilitation and 6 months following the start of pulmonary rehabilitation No
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT04905693 - Extension Study of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis Phase 3
Recruiting NCT05631132 - May Noninvasive Mechanical Ventilation (NIV) and/or Continuous Positive Airway Pressure (CPAP) Increase the Bronchoalveolar Lavage (BAL) Salvage in Patients With Pulmonary Diseases? N/A
Recruiting NCT05417776 - Collagen-targeted PET Imaging for Early Interstitial Lung Disease Phase 2
Not yet recruiting NCT04089826 - Long Term Oxygen Therapy in Patients With Interstitial Lung Disease
Recruiting NCT03467880 - Multicenter Study of Impulse Oscillometry in Chinese N/A
Completed NCT00883129 - Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II) Phase 2
Completed NCT00362739 - Blood Collection From Individuals With Lung Disease for Genetic Studies N/A
Recruiting NCT06133998 - Effects of Incentive Spirometry With and Without Aerobic Exercises in Interstitial Lung Disease N/A
Active, not recruiting NCT03485378 - Assessment of Precision Irradiation in Early NSCLC and Interstitial Lung Disease N/A
Recruiting NCT04098094 - Outcomes of RV Dysfunction in Acute Exacerbation of Chronic Respiratory Diseases
Recruiting NCT03400839 - Best Clinical Endpoints That Likely Induce Worse Prognosis in Interstitial Lung Diseases
Terminated NCT02633293 - An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE Phase 2/Phase 3
Enrolling by invitation NCT05001009 - Goals of Care Conversations Study N/A
Active, not recruiting NCT05068869 - Digital Outpatient Services N/A
Active, not recruiting NCT03727568 - Study Comparing Two Different Methods of Cryobiopsy in the Interstitial Lung Diseases N/A
Recruiting NCT06046547 - Integrating Palliative Care Education in Pulmonary Rehabilitation N/A
Completed NCT04946708 - Virtual Exercise Program in Interstitial Lung Disease (ILD) Patients N/A
Recruiting NCT04139356 - The Effect of Spontaneous Respiration on Pulse-oximetry Measurements N/A
Recruiting NCT03726398 - CompRehensive Phenotypic Characterization of Patients With Scleroderma-Associated ILD and PH Phase 2/Phase 3
Active, not recruiting NCT03295279 - WTC Chest CT Imaging Archive